EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Chronic and emerging immune-related adverse events from immune checkpoint inhibitors

Connor Frey

Disease and Therapeutics · 2026 · 2 · 100011

DOI: 10.1016/j.dist.2026.100011 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Disease and Therapeutics, 2026. Verfasst von Connor Frey. Die Arbeit nennt 217 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Frey, C. (2026). Chronic and emerging immune-related adverse events from immune checkpoint inhibitors. Disease and Therapeutics, 2, 100011. https://doi.org/10.1016/j.dist.2026.100011

Vancouver

Frey C. Chronic and emerging immune-related adverse events from immune checkpoint inhibitors. Disease and Therapeutics. 2026;2:100011. doi:10.1016/j.dist.2026.100011

BibTeX
@article{Frey2026,
  author = {Frey, Connor},
  title = {Chronic and emerging immune-related adverse events from immune checkpoint inhibitors},
  journal = {Disease and Therapeutics},
  year = {2026},
  volume = {2},
  pages = {100011},
  doi = {10.1016/j.dist.2026.100011}
}
Kostenlos starten →